# A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers

> **NCT00504816** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 22 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** GSK189075
- **DRUG:** Brevicon

## Key facts

- **NCT ID:** NCT00504816
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2008-01
- **Final completion:** 2008-04
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2012-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00504816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00504816, "A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00504816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*